Sept 2 (Reuters) - Allena Pharmaceuticals Inc ALNA.O :
* ALLENA PHARMACEUTICALS INC - FILED A VOLUNTARY PETITION
FOR
RELIEF UNDER THE PROVISIONS OF CHAPTER 11 OF TITLE 11 OF THE
UNITED STATES CODE
* ALLENA PHARMACEUTICALS INC - HAS APPOINTED MATTHEW FOSTER
AS THE
COMPANY’S CHIEF RESTRUCTURING OFFICER, EFFECTIVE AS OF SEPTEMBER
2, 2022
* ALLENA PHARMACEUTICALS- TERMINATED EMPLOYMENT OF
SUBSTANTIALLY
ALL OF ITS EMPLOYEES, INCLUDING LOUIS BRENNER, PRESIDENT AND CEO
AND RICHARD KATZ, CFO
* ALLENA PHARMACEUTICALS- INTENDS TO CONTINUE TO OPERATE
ITS
BUSINESS AT REDUCED LEVEL AS A “DEBTOR-IN-POSSESSION” UNDER THE
JURISDICTION OF COURT
Further company coverage: ALNA.O
((Reuters.Briefs@thomsonreuters.com;))